๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Propranolol for Prevention of Recurrent Gastrointestinal Bleeding in Patients with Cirrhosis

โœ Scribed by Lebrec, Didier; Poynard, Thierry; Hillon, Patrick; Benhamou, Jean-Pierre


Book ID
118000794
Publisher
Massachusetts Medical Society
Year
1981
Tongue
English
Weight
631 KB
Volume
305
Category
Article
ISSN
0096-6762

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Propranolol for prevention of recurrent
โœ Thierry Poynard; Didier Lebrec; Patrick Hillon; Raymond Sayegh; Jacques Bernuau; ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 578 KB

In a previous randomized trial, we demonstrated that propranolol prevented recurrent gastrointestinal bleeding in patients with cirrhosis. We have undertaken the present study in a new group of patients to ascertain the factors associated with rebleeding. Among 232 patients with cirrhosis admitted f

A Randomized Controlled Study of Propran
โœ Didier Lebrec; Thierry Poynard; Jacques Bernuau; Eric Bercoff; Olivier Nouel; Je ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 466 KB ๐Ÿ‘ 2 views

We have previously reported the results of a controlled trial showing that continuous oral administration of propranolol reduced the risk of recurrent gastrointestinal bleeding in patients with cirrhosis; only part of our patients had been followed for 1 year. This controlled trial was continued for

Propranolol for prevention of recurrent
โœ Harvey Licht; Alan Mermelstein; Didier Lebrec; Thierry Poynard; Jacques Bernuau; ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 86 KB
ฮฒ-blockade prevents recurrent gastrointe
โœ Massimo Colombo; Roberto de Franchis; Maurizio Tommasini; Angelo Sangiovanni; Ni ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 708 KB

To assess the efficacy of &blockers in preventing rebleeding in selected cirrhotic patients and to compare the tolerance, safety and patient compliance of a selective and a nonselective @-blocker, 9 4 patients were randomly assigned to propranolol (32 patients), atenolol (32 patients) or placebo (30